{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:36:35Z","timestamp":1791502595202,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.chest.2018.06.038","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T14:58:11Z","timestamp":1532098691000},"page":"904-917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Treatment of Interstitial Lung Disease Associated Cough"],"prefix":"10.1016","volume":"154","author":[{"given":"Surinder S.","family":"Birring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne E.","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina A.","family":"Keogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiser G.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan F.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder S.","family":"Birring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Blackhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Philippe","family":"Boulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney S.","family":"Braman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Brightling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Callahan-Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne B.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"El Solh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Escalante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen K.","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia T.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Harnden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam T.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Kahrilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina A.","family":"Keogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiser","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Mark","family":"Madison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Malesker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorcan","family":"McGarvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Molasoitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hassan","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangala","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong Q.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Newcombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos I.","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Tarlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Turmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Vertigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"141","key":"10.1016\/j.chest.2018.06.038_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1183\/16000617.0090-2015","article-title":"Cough in idiopathic pulmonary fibrosis","volume":"25","author":"van Manen","year":"2016","journal-title":"Eur Respir Rev"},{"issue":"1","key":"10.1016\/j.chest.2018.06.038_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1745-9974-6-4","article-title":"Objective cough frequency in idiopathic pulmonary fibrosis","volume":"6","author":"Key","year":"2010","journal-title":"Cough"},{"issue":"1","key":"10.1016\/j.chest.2018.06.038_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1477-7525-3-61","article-title":"Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives","volume":"3","author":"Swigris","year":"2005","journal-title":"Health Quality Life Outcomes"},{"issue":"6","key":"10.1016\/j.chest.2018.06.038_bib4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1440-1843.2011.01996.x","article-title":"Cough predicts prognosis in idiopathic pulmonary fibrosis","volume":"16","author":"Ryerson","year":"2011","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.chest.2018.06.038_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-9974-7-2","article-title":"Mechanical induction of cough in idiopathic pulmonary fibrosis","volume":"7","author":"Jones","year":"2011","journal-title":"Cough"},{"issue":"2","key":"10.1016\/j.chest.2018.06.038_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00011-004-1321-x","article-title":"Sputum eosinophilia in idiopathic pulmonary fibrosis","volume":"54","author":"Birring","year":"2005","journal-title":"Inflammation Res"},{"issue":"12","key":"10.1016\/j.chest.2018.06.038_bib7","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/thorax.55.12.1028","article-title":"Capsaicin induced cough in cryptogenic fibrosing alveolitis","volume":"55","author":"Doherty","year":"2000","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.chest.2018.06.038_bib8","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1164\/ajrccm.158.6.9804105","article-title":"Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis","volume":"158","author":"Tobin","year":"1998","journal-title":"Am J Respir Crit Car Med"},{"issue":"5","key":"10.1016\/j.chest.2018.06.038_bib9","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1183\/13993003.01369-2015","article-title":"Predictors of objective cough frequency in pulmonary sarcoidosis","volume":"47","author":"Sinha","year":"2016","journal-title":"Eur Respir J"},{"issue":"25","key":"10.1016\/j.chest.2018.06.038_bib10","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.chest.2018.06.038_bib11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2018.06.038_bib12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.14-0824","article-title":"Methodologies for the development of CHEST guidelines and expert panel reports","volume":"146","author":"Lewis","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.chest.2018.06.038_bib13","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1016\/j.chest.2018.06.038_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/bmjqs-2013-002293.184","article-title":"P154 development of the documentation and appraisal review tool (Dart) for systematic reviews","volume":"22","author":"Diekemper","year":"2013","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.chest.2018.06.038_bib15","doi-asserted-by":"crossref","unstructured":"Viswanathan M, Ansari MT, Berkman ND, et\u00a0al. Assessing the risk of bias of individual studies in systematic reviews of health care interventions. Agency for Healthcare Research and Quality Methods Guide for Comparative Effectiveness Reviews. March 2012. www.effectivehealthcare.ahrq.gov\/. Accessed August 31, 2018.","DOI":"10.23970\/AHRQEPCMETHGUIDE2"},{"issue":"7001","key":"10.1016\/j.chest.2018.06.038_bib16","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.chest.2018.06.038_bib17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/thoraxjnl-2012-202040","article-title":"Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature","volume":"68","author":"Bajwah","year":"2013","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.chest.2018.06.038_bib18","first-page":"CD001114","article-title":"Corticosteroids for pulmonary sarcoidosis","author":"Paramothayan","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"20","key":"10.1016\/j.chest.2018.06.038_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19200","article-title":"The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation","volume":"19","author":"Loveman","year":"2015","journal-title":"Health Technology Assessment"},{"issue":"10","key":"10.1016\/j.chest.2018.06.038_bib20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S2213-2600(17)30310-7","article-title":"A\u00a0novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial","volume":"5","author":"Birring","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.chest.2018.06.038_bib21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.chest.2016.11.052","article-title":"Improved cough and cough-specific quality of life in patients treated for scleroderma-related interstitial lung disease: results of Scleroderma Lung Study II","volume":"151","author":"Tashkin","year":"2017","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2018.06.038_bib22","doi-asserted-by":"crossref","first-page":"1701157","DOI":"10.1183\/13993003.01157-2017","article-title":"Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis","volume":"50","author":"van Manen","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2018.06.038_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1465-9921-12-143","article-title":"Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment","volume":"12","author":"Azuma","year":"2011","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.chest.2018.06.038_bib24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1183\/09031936.00005209","article-title":"Pirfenidone in idiopathic pulmonary fibrosis","volume":"35","author":"Taniguchi","year":"2010","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.chest.2018.06.038_bib25","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/thx.2006.060087","article-title":"Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms","volume":"61","author":"Ford","year":"2006","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.chest.2018.06.038_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1745-9974-10-4","article-title":"Effect of acid suppression therapy on gastroesophageal reflux and cough in idiopathic pulmonary fibrosis: an intervention study","volume":"10","author":"Kilduff","year":"2014","journal-title":"Cough"},{"issue":"3","key":"10.1016\/j.chest.2018.06.038_bib27","first-page":"198","article-title":"Use of fluticasone in acute symptomatic pulmonary sarcoidosis","volume":"19","author":"Baughman","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"6","key":"10.1016\/j.chest.2018.06.038_bib28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1183\/09031936.99.13613519","article-title":"Randomized trial of inhaled fluticasone propionate in chronic stable pulmonary sarcoidosis: a pilot study","volume":"13","author":"du Bois","year":"1999","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2018.06.038_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2796.1994.tb00798.x","article-title":"No effect of high-dose inhaled steroids in pulmonary sarcoidosis: a double-blind, placebo-controlled study","volume":"236","author":"Milman","year":"1994","journal-title":"J\u00a0Intern Med"},{"issue":"3","key":"10.1016\/j.chest.2018.06.038_bib30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1378\/chest.11-0801","article-title":"Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: findings from the Scleroderma Lung Study","volume":"142","author":"Theodore","year":"2012","journal-title":"Chest"},{"issue":"22","key":"10.1016\/j.chest.2018.06.038_bib31","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A\u00a0phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"9779","key":"10.1016\/j.chest.2018.06.038_bib32","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.chest.2018.06.038_bib33","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2018.06.038_bib34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/0003-4819-157-6-201209180-00003","article-title":"Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial","volume":"157","author":"Horton","year":"2012","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.chest.2018.06.038_bib35","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am J Respir Crit Car Med"},{"issue":"2","key":"10.1016\/j.chest.2018.06.038_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2036.2010.04511.x","article-title":"Randomised clinical trial: high-dose acid suppression for chronic cough\u2014a double-blind, placebo-controlled study","volume":"33","author":"Shaheen","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.chest.2018.06.038_bib37","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1440-1843.2011.02014.x","article-title":"Chronic cough and esomeprazole: a double-blind placebo-controlled parallel study","volume":"16","author":"Faruqi","year":"2011","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.chest.2018.06.038_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1378\/chest.15-1496","article-title":"Treatment of unexplained chronic cough: CHEST guideline and expert panel report","volume":"149","author":"Gibson","year":"2016","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.chest.2018.06.038_bib39","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/thx.2006.064337","article-title":"Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy","volume":"61","author":"Vertigan","year":"2006","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.chest.2018.06.038_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1745-9974-6-5","article-title":"Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough","volume":"6","author":"Ryan","year":"2010","journal-title":"Cough"},{"issue":"2","key":"10.1016\/j.chest.2018.06.038_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/thoraxjnl-2016-208843","article-title":"Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial","volume":"72","author":"Mitchell","year":"2017","journal-title":"Thorax"},{"issue":"9853","key":"10.1016\/j.chest.2018.06.038_bib42","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0140-6736(12)60776-4","article-title":"Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Ryan","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.chest.2018.06.038_bib43","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1378\/chest.15-1271","article-title":"Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomized controlled trial","volume":"149","author":"Vertigan","year":"2016","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2018.06.038_bib44","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1164\/rccm.200607-892OC","article-title":"Opiate therapy in chronic cough","volume":"175","author":"Morice","year":"2007","journal-title":"Am J Respir Crit Car Med"},{"key":"10.1016\/j.chest.2018.06.038_bib45","unstructured":"The National Institute for Health and Care Excellence. Palliative Care\u2014Cough. Clinical Knowledge Summaries 2016. www.cks.nice.org.uk\/palliative-care-cough."},{"issue":"15","key":"10.1016\/j.chest.2018.06.038_bib46","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.chest.2018.06.038_bib47","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.chest.2017.05.016","article-title":"Translating cough mechanisms into better cough suppressants","volume":"152","author":"Keller","year":"2017","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2018.06.038_bib48","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1183\/09031936.00218613","article-title":"Expert opinion on the cough hypersensitivity syndrome in respiratory medicine","volume":"44","author":"Morice","year":"2014","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.chest.2018.06.038_bib49","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/rccm.200304-597OC","article-title":"A\u00a0study of the cough reflex in idiopathic pulmonary fibrosis","volume":"168","author":"Hope-Gill","year":"2003","journal-title":"Am J Respir Crit Car Med"},{"issue":"21","key":"10.1016\/j.chest.2018.06.038_bib50","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.chest.2018.06.038_bib51","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2174\/138955709788452595","article-title":"Thalidomide chemotherapy-induced peripheral neuropathy: actual status and new perspectives with thalidomide analogues derivatives","volume":"9","author":"Cundari","year":"2009","journal-title":"Mini Rev Med Chem"},{"issue":"4","key":"10.1016\/j.chest.2018.06.038_bib52","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1183\/09031936.06.00131505","article-title":"Thalidomide reduces IL-18, IL-8 and TNF-\u03b1 release from alveolar macrophages in interstitial lung disease","volume":"28","author":"Ye","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2018.06.038_bib53","series-title":"National Institute for Health and Clinical Excellence: Guidance. Idiopathic pulmonary fibrosis. Diagnosis and Management of Suspected Idiopathic Pulmonary Fibrosis","year":"2013"},{"issue":"3","key":"10.1016\/j.chest.2018.06.038_bib54","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1378\/chest.14-2506","article-title":"Tools for assessing outcomes in studies of chronic cough: CHEST guideline and expert panel report","volume":"147","author":"Boulet","year":"2015","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2018.06.038_bib55","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thorax.58.4.339","article-title":"Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)","volume":"58","author":"Birring","year":"2003","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.chest.2018.06.038_bib56","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1378\/chest.12-2870","article-title":"Validation of the Cough Quality-of-Life Questionnaire in patients with idiopathic pulmonary fibrosis","volume":"143","author":"Lechtzin","year":"2013","journal-title":"Chest"},{"issue":"9974","key":"10.1016\/j.chest.2018.06.038_bib57","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(14)61255-1","article-title":"P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study","volume":"385","author":"Abdulqawi","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.chest.2018.06.038_bib58","first-page":"A7608","article-title":"MK-7264, A P2X3 receptor antagonist, reduces cough frequency in patients with refractory chronic cough: results from a randomized, controlled, phase 2b clinical trial","volume":"195","author":"Smith","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2018.06.038_bib59","first-page":"A2672","article-title":"The neurokinin-1 receptor antagonist orvepitant is a novel anti-tussive therapy for chronic refractory cough: results from a phase 2 Study (VOLCANO-1)","volume":"195","author":"Smith","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2018.06.038_bib60","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaci.2015.10.044","article-title":"Transient receptor potential cation channel, subfamily V, member 4 and airway sensory afferent activation: Role of adenosine triphosphate","volume":"138","author":"Bonvini","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369218310754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369218310754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:03:16Z","timestamp":1757923396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369218310754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0012369218310754"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2018.06.038","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Interstitial Lung Disease Associated Cough","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2018.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}